Sucampo Announces Second Quarter 2017 Earnings Call
19 juil. 2017 16h05 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., July 19, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its second quarter 2017...
Dr. Karen Smith Joins Sucampo’s Board of Directors
18 juil. 2017 16h05 HE
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., July 18, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that Karen Smith, M.D., Ph.D., M.B.A.,...
Sucampo and Takeda Announce Update on Liquid Formulation Program for AMITIZA(R) (lubiprostone)
14 mars 2014 17h29 HE
|
Sucampo Pharmaceuticals Inc
BETHESDA, Md., March 14, 2014 (GLOBE NEWSWIRE) -- Sucampo Pharma Americas, LLC, a wholly owned subsidiary of Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), and its development and...